Clinical Utility of Measurement of Vitamin D-Binding Protein and Calculation of Bioavailable Vitamin D in Assessment of Vitamin D Status
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Background: The associations of vitamin D deficiency with various clinical conditions highlighted the importance of vitamin D testing. Currently, clinicians measure only the total 25-hydroxyvitamin D [25(OH)D] concentration, regardless of its bioavailability. We aimed to determine the effect of vitamin D-binding protein (VDBP) on 25(OH)D bioavailability. Methods: Serum samples were collected from 60 healthy controls, 50 pregnant women, and 50 patients in intensive care units (ICUs). Total 25(OH)D was quantified by liquid chromatography with tandem mass spectrometry, and VDBP levels were determined by using an ELISA kit (R&D Systems, USA). The bioavailable 25(OH)D levels were calculated by using total 25(OH)D, VDBP, and albumin concentrations. Results: In comparison with healthy controls, the total 25(OH)D concentration was significantly lower in ICU patients (median, 11.65 vs 18.25 ng/mL; P<0.00001), but no significant difference was noted between pregnant women (18.25 ng/mL) and healthy controls. The VDBP level was significantly lower in ICU patients (95.58 vs 167.18 μg/mL, P=0.0002) and higher in pregnant women (225.01 vs 167.18 μg/mL, P=0.008) compared with healthy controls. Nonetheless, the calculated bioavailable 25(OH)D levels of ICU patients and pregnant women were significantly lower than those of healthy controls (1.97 and 1.93 ng/mL vs 2.56 ng/mL; P=0.0073 and 0.0027). Conclusions: A single marker of the total 25(OH)D level is not sufficient to accurately evaluate vitamin D status, especially in pregnant women. In cases where VDBP concentrations may be altered, VDBP measurements and bioavailable 25(OH)D calculations may help to determine vitamin D status accurately.
Abstract
Background: The associations of vitamin D deficiency with various clinical conditions highlighted the importance of vitamin D testing. Currently, clinicians measure only the total 25-hydroxyvitamin D [25(OH)D] concentration, regardless of its bioavailability. We aimed to determine the effect of vitamin D-binding protein (VDBP) on 25(OH)D bioavailability. Methods: Serum samples were collected from 60 healthy controls, 50 pregnant women, and 50 patients in intensive care units (ICUs). Total 25(OH)D was quantified by liquid chromatography with tandem mass spectrometry, and VDBP levels were determined by using an ELISA kit (R&D Systems, USA). The bioavailable 25(OH)D levels were calculated by using total 25(OH)D, VDBP, and albumin concentrations. Results: In comparison with healthy controls, the total 25(OH)D concentration was significantly lower in ICU patients (median, 11.65 vs 18.25 ng/mL; P<0.00001), but no significant difference was noted between pregnant women (18.25 ng/mL) and healthy controls. The VDBP level was significantly lower in ICU patients (95.58 vs 167.18 μg/mL, P=0.0002) and higher in pregnant women (225.01 vs 167.18 μg/mL, P=0.008) compared with healthy controls. Nonetheless, the calculated bioavailable 25(OH)D levels of ICU patients and pregnant women were significantly lower than those of healthy controls (1.97 and 1.93 ng/mL vs 2.56 ng/mL; P=0.0073 and 0.0027). Conclusions: A single marker of the total 25(OH)D level is not sufficient to accurately evaluate vitamin D status, especially in pregnant women. In cases where VDBP concentrations may be altered, VDBP measurements and bioavailable 25(OH)D calculations may help to determine vitamin D status accurately.
참고문헌 (25)
- DeLuca HF, "Overview of general physiologic features and functions of vitamin D", Am J Clin Nutr, 80(S6), pp.S1689~S1696 (2004)
- Holick MF, "Vitamin D deficiency", N Engl J Med, 357, pp.266~281 (2007)
- Bhan I, "Bioavailable vitamin D is more tightly linked to mineral metabolism than total vitamin D in incident hemodialysis patients", Kidney Int, 82, pp.84~89 (2012)
- Bikle DD, "Assessment of the free fraction of 25-hydroxyvitamin D in serum and its regulation by albumin and the vitamin D-binding protein", J Clin Endocrinol Metab, 63, pp.954~959 (1986)
- Bikle DD, "Serum protein binding of 1,25-dihydroxyvitamin D: a reevaluation by direct measurement of free metabolite levels", J Clin Endocrinol Metab, 61, pp.969~975 (1985)
- Chun RF, "New perspectives on the vitamin D binding protein", Cell Biochem Funct, 30, pp.445~456 (2012)
- Bhan I, "Vitamin D binding protein and bone health", Int J Endocrinol, 2014, pp.561214~ (2014)
- Heijboer AC, "Accuracy of 6 routine 25-hydroxyvitamin D assays: influence of vitamin D binding protein concentration", Clin Chem, 58, pp.543~548 (2012)
- Schwartz JB, "A comparison of meassured and calculated and free 25(OH) vitamin D levels in clinical populations", J Clin Endocrinol Metab, 99, pp.1631~1637 (2014)
- Arnaud J, "Affinity differences for vitamin D metabolites associated with the genetic isoforms of the human serum carrier protein (DBP)", Hum Genet, 92, pp.183~188 (1993)
- Thacher TD, "Vitamin D insufficiency", Mayo Clin Proc, 86, pp.50~60 (2011)
- Lappe JM, "Vitamin D and calcium supplementation reduces cancer risk: results of a randomized trial", Am J Clin Nutr, 85, pp.1586~1591 (2007)
- Mitchell D, "The relationship between vitamin D and cancer", Clin J Oncol Nurs, 15, pp.557~560 (2011)
- Mann MC, "Vitamin D, the autonomic nervous system, and cardiovascular risk", Physiol Rep, 3, pp.e12349~ (2015)
- Garlanad CF, "The role of vitamin D in cancer prevention", Am J Public Health, 96, pp.252~261 (2006)
- Ponsonby AL, "Ultraviolet radiation and autoimmune disease: insights from epidemiological research", Toxicology, 181-182, pp.71~78 (2002)
- McGrath J, "Long-term trends in sunshine duration and its association with schizophrenia birth rates and age at first registration-data from Australia and the Netherlands", Schizophr Res, 54, pp.199~212 (2002)
- Iglar PJ, "Vitamin D status and surgical outcomes: a systematic review", Patient Saf Surg, 9, pp.14~23 (2015)
- Cleal JK, "Placental amino acid transport may be regulated by maternal vitamin D and vitamin D-binding protein: results from the Southampton Women’s Survey", Br J Nutr, 113, pp.1903~1910 (2015)
- Shao H, "Vitamin D levels and other factors related to bone mineral density during pregnancy", Aust N Z J Obstet Gynaecol, 52, pp.571~575 (2012)
- Bouillon R, "Influence of the vitamin-D binding protein on the serum concentration of 1,25-dihydroxyvitamin D3. Significance of the free 1,25-dihydroxyvitamin D3 concentration", J Clin Invest, 67, pp.589~596 (1981)
- Powe CE, "Vitamin D-binding protein and vitamin D status of black Americans and white Americans", N Engl J Med, 369, pp.1991~2000 (2013)
- Bikle DD, "Free 1,25-dihydroxy vitamin D levels in serum from normal subject, pregnant subjects, and subjects with liver disease", J Clin Invest, 74, pp.1966~1971 (1984)
- Pop LC, "Vitamin D-binding protein in healthy pre- and postmenopausal women: relationship with estradiol concentrations", Endocr Pract, 21, pp.936~942 (2015)
- Kamboh MI, "Ethnic variation in vitamin D-binding protein (GC): a review of isoelectric focusing studies in human populations", Hum Genet, 72, pp.281~293 (1986)